✦ LIBER ✦

A phase II study of docetaxel (D) and gemcitabine (G) as second-line treatment in patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Agelaki, S.; Papadakis, E.; Tsiafaki, X.; Rapti, A.; Toubis, M.; Bania, E.; Kalbakis, K.; Kouroussis, C.; Androulakis, N.; Georgoulias, V.

Book ID: 123591980
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 158 KB
Volume: 35
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(99)81436-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of docetaxel (DOC) and ca

Phase II study of docetaxel (DOC) and carboplatin (CP) as second-line treatment in patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ van Putten, J.W.G; Slebos, D.J; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

A phase I–II study of docetaxel (D) and

A phase I–II study of docetaxel (D) and gemcitabine (G) combination in patients (pts) with non-small cell lung cancer (NSCLC)

✍ Quantin, X; Rebattu, P; Pujol, J; Morere, J; Azarian, M.R; Khial, F; Dumortier, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Second-line treatment with single-agent

Second-line treatment with single-agent gemcitabine (GEM) in patients (PTS) with advanced non-small-cell lung cancer (NSCLC)

✍ van Putten, J.W.G; Baas, P; Codrington, H; Kwa, H.B; Groen, H.J.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A phase II study of Gemcitabine (G) plus

A phase II study of Gemcitabine (G) plus Docetaxel (D) as first line chemotherapy for advanced NSCLC patients (PTS)

✍ Ventriglia, M; Estevez, R; Cabrera, L; Spector, C; Álvarez, A.A; Cilurzo, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

P-531 Phase II study of sequential gemci

P-531 Phase II study of sequential gemcitabine (G) and carboplatin (C) followed by docetaxel (D) as first line chemotherapy for patients (pts) with advanced non-small cell lung cancer (NSCLC)

✍ Chiappori, Alberto; Simon, George; Lima, Caio Rocha; Williams, Charles; Haura, E 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 360 KB

Open, Randomized, Phase II Study of Sing

Open, Randomized, Phase II Study of Single-Agent Gemcitabine and Docetaxel as First- and Second-Line Treatment in Patients with Advanced Non–Small-Cell Lung Cancer

✍ Christian Manegold; Gabriele Koschel; Dagmar Hruska; Kathrin Schott-von-Römer; J 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 155 KB